Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HAE | Common Stock | Award | +3.36K | +19.29% | 20.8K | May 15, 2023 | Direct | F1, F2, F3 | ||
transaction | HAE | Common Stock | Tax liability | -$28.4K | -318 | -1.53% | $89.21 | 20.5K | May 16, 2023 | Direct | F3, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HAE | Non-qualified Stock Option (Right to Buy) | Award | $0 | +7.6K | $0.00 | 7.6K | May 15, 2023 | Common Stock | 7.6K | $89.16 | Direct | F5 |
Id | Content |
---|---|
F1 | The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. |
F2 | Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. |
F3 | This number includes unvested RSUs previously reported as well as 297 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 28, 2023. |
F4 | Represents shares withheld for tax obligations in connection with the vesting of certain RSUs previously reported in Table I. |
F5 | Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |